149 related articles for article (PubMed ID: 17483365)
1. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
Saudemont A; Hamrouni A; Marchetti P; Liu J; Jouy N; Hetuin D; Colucci F; Quesnel B
Cancer Res; 2007 May; 67(9):4491-8. PubMed ID: 17483365
[TBL] [Abstract][Full Text] [Related]
2. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells.
Zitzmann K; Brand S; De Toni EN; Baehs S; Göke B; Meinecke J; Spöttl G; Meyer HH; Auernhammer CJ
Cancer Res; 2007 May; 67(10):5025-32. PubMed ID: 17510435
[TBL] [Abstract][Full Text] [Related]
3. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
[TBL] [Abstract][Full Text] [Related]
4. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
6. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.
Svensson E; Vidovic K; Lassen C; Richter J; Olofsson T; Fioretos T; Gullberg U
Leukemia; 2007 Dec; 21(12):2485-94. PubMed ID: 17728783
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients.
Elias MH; Azlan H; Baba AA; Ankathil R
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):234-238. PubMed ID: 29669505
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
10. Janus kinase 2: a critical target in chronic myelogenous leukemia.
Samanta AK; Lin H; Sun T; Kantarjian H; Arlinghaus RB
Cancer Res; 2006 Jul; 66(13):6468-72. PubMed ID: 16818614
[TBL] [Abstract][Full Text] [Related]
11. In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.
Kindler T; Breitenbuecher F; Kasper S; Stevens T; Carius B; Gschaidmeier H; Huber C; Fischer T
Leukemia; 2003 Jun; 17(6):999-1009. PubMed ID: 12764361
[TBL] [Abstract][Full Text] [Related]
12. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia.
Chen CY; Tsay W; Tang JL; Shen HL; Lin SW; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
Genes Chromosomes Cancer; 2003 Jul; 37(3):300-5. PubMed ID: 12759928
[TBL] [Abstract][Full Text] [Related]
13. [Effect of SOCS1 Gene on Growth Inhibition of Acute Myeloid Leukemia Cells Mediated by JAK2/STAT Signaling Pathway].
Zhang XH; Luo JM; Yang L; Liu XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1496-1503. PubMed ID: 33067944
[TBL] [Abstract][Full Text] [Related]
14. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
[TBL] [Abstract][Full Text] [Related]
15. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Williams RT; Sherr CJ
Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
[TBL] [Abstract][Full Text] [Related]
16. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
Rahmani M; Nguyen TK; Dent P; Grant S
Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein.
Shimizu T; Miyakawa Y; Iwata S; Kuribara A; Tiganis T; Morimoto C; Ikeda Y; Kizaki M
Exp Hematol; 2004 Nov; 32(11):1057-63. PubMed ID: 15539083
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts.
Li J; Gong J; Li P; Li M; Liu Y; Liang S; Gong J
Transplantation; 2014 Mar; 97(6):626-35. PubMed ID: 24531847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
